M32
Conditions
Interventions
Group 1: We will included Patients = 18 years, who have been diagnosed with SLE according to the 2019 EULAR / ACR criteria and whoe are able to understand the nature and individual consequences of par
Sponsors
Universitätsklinikum Köln - Klinik II für Innere Medizin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. signed informed consent form 2. patients = 18 years of age with a diagnosis of systemic lupus erythematosus according to the EULAR/ ACR criteria of 2019
Exclusion criteria
Exclusion criteria: 1. refusal of participation 2. patients < 18 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| As this is clinical registry, no primary endpoint was defined. The aim of the registry is to collect clinical data longitudinally to detect patient characteristics that are associated with a certain outcome of the the disease. This will pave the way for the development of individualized disease management strategies. Furthermore we will collect biomaterial (e.g. blood and urine) to identify novel biomarkers or pathogenic cellular mechanisms. | — |
Secondary
| Measure | Time frame |
|---|---|
| As this is a clinical registry, no secondary outcome was defined. | — |
Countries
Germany
Outcome results
None listed